Aastrom Biosciences (ASTM)

2.05 -0.01  -0.49%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart ASTM Price Chart

Key Stats

Market Cap 79.46M
Revenue Growth -77.78%
Profit Margin -487200%
Earnings Yield -30.73%
Dividend Yield 0.00%
Earnings Per Share TTM -0.63
PE Ratio
Price / Sales Ratio
52 Week High 3.47
52 Week Low 1.75
Beta 0.0939
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 22 This Just In: More Upgrades and Downgrades Fool
May 22 Correction - Needham & Company initiates coverage on Aastrom Biosciences (ASTM) at 'B...
May 22 Needham & Company Maintains a 'Buy' on Aastrom Biosciences (ASTM); Late-Stage Cell Th...
May 18 AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers
May 17 Osiris stem-cell therapy wins Canadian approval
May 17 $ASTM 200 Day SMA Cross - Price crossed below 200 day SMA (2.2097). Confirmed by volume. by TradeIdeasQuant
May 17 Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine Congress GlobeNewswire
May 16 $SD $ASTM $DNKN Wednesday's Top Upgrades (and Downgrades) http://stks.co/3rRG by DrNick
May 16 $SD $ASTM $DNKN by DrNick
May 16 $ASTM 200 Day SMA Cross - Price crossed below 200 day SMA (2.2119). Confirmed by volume. by TradeIdeasQuant
May 16 RT @Briefingcom $ASTM: Ascendiant Capital Markets starts at Strong Buy by forsale1410

Profile

Exchange: NASDAQCM       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aastrom Biosciences is down 33.87% over the last year vs S&P 500 Total Return up 1.62%, StemCells down 88.68%, and Athersys down 52.05%.

  • ASTM Total Returns
  • ^SPXTR Total Returns
  • STEM Total Returns
  • ATHX Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring ASTM

Did Aastrom Biosciences make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

ASTM Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
ASTM 2.05 -0.01 -0.49% 79.46M
ASTI 0.5391 -0.02 -3.73% 22.08M
ASTE 28.39 -0.11 -0.39% 644.74M
BBOX 22.22 +0.19 +0.86% 388.41M
BBNK 15.01 +0.03 +0.20% 227.70M
BBL 53.22 -0.73 -1.35% 56.90B
BBH 46.16 +0.28 +0.61%
BBGI 5.76 +0.00 +0.00% 130.98M
BBG 20.65 +0.31 +1.52% 987.90M
BBEP 16.70 -0.08 -0.48% 1.155B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close